Key indicators: single-crystal X-ray study; T = 200 K; mean (C-C) = 0.002 Å; R factor = 0.037; wR factor = 0.093; data-to-parameter ratio = 13.6.
In the asymmetric unit of the title co-crystal, C 7 H 5 NO 4 Á-C 12 H 14 N 4 O 2 S, there are two independent but conformationally similar heterodimers, which are formed through intermolecular N-HÁ Á ÁO carboxy and carboxyl-pyrimidine O-HÁ Á ÁN hydrogen-bond pairs, giving a cyclic motif [graph set R 2 2 (8)]. The dihedral angles between the rings in the sulfonamide molecules are 78.77 (8) and 82.33 (9) while the dihedral angles between the ring and the CO 2 H group in the acids are 2.19 (9) and 7.02 (10) . A two-dimensional structure parallel to the ab plane is generated from the heterodimer units through hydrogen-bonding associations between NH 2 and sulfone groups. Between neighbouring two-dimensional arrays there are two types of aromatic -stacking interactions involving either one of the pyrimidine rings and a 4-nitrobenzoic acid molecule [minimum ring centroid separation = 3.5886 (9) Å ] or two acid molecules [minimum ring centroid separation = 3.7236 (10) Å ].
Related literature
For background on sulfamethazole as a model for co-crystal formation, see: Caira (2008) . For structures of 1:1 adducts of sulfamethazine with benzoic acid analogues, see: Arman et al. (2010); Caira (1991 Caira ( , 1992 ; Lynch et al. (2000) ; Patel et al. (1988) . For graph-set analysis, see: Etter et al. (1990) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
The drug sulfamethazine [4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide] has been used as a model for cocrystal formation (Caira, 2008) , commonly forming 1:1 adducts with carboxylic acids, particularly the benzoic analogues.
The structures of a number of these have been reported, e.g. with benzoic acid (Arman et al., 2010) ; salicylic acid (Patel et al., 1988) ; anthranilic acid and 4-aminobenzoic acid (Caira, 1991); 4-aminosalicylic acid and acetylsalicylic acid (Caira, 1992) and 2,4-dinitrobenzoic acid (Lynch et al., 2000) . In all of these co-crystals, heterodimers are formed through a cyclic hydrogen-bonding motif [graph set R 2 2 (8) (Etter et al., 1990) ], involving amine N-H···O carboxyl -carboxylic acid O-H···N pyrimidine pairs.
Our 1:1 stoichiometric interaction of sulfamethazine with 4-nitrobenzoic acid also gave a 1:1 co-crystalline adduct C 12 H 14 N 4 O 2 S . C 7 H 5 NO 4 , the title compound, and the structure is reported here. In this co-crystal ( Fig. 1) , there are two independent molecular pairs (sulfamethazine molecules A and B with 4-nitrobenzoic acid molecules C and D respectively), which interact as previously described, giving cyclic R 2 2 (8) hydrogen-bonded heterodimers (Table 1) . Intermolecular amine N-H···O sulfone hydrogen-bonding interactions from the heterodimer units (Table 1) 
Experimental
The title compound was formed in the interaction of 1 mmol quantities of 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (sulfamethazine) and 4-nitrobenzoic acid in 50 ml of 50% ethanol-water with 10 min refluxing.
Partial evaporation of the solvent gave pale yellow crystal prisms (m.p. 482 K) from which a specimen was cleaved for the X-ray analysis.
Refinement
Hydrogen atoms potentially involved in hydrogen-bonding interactions were located by difference methods and their positional and isotropic displacement parameters were refined. Other H atoms were included at calculated positions Table 1 .
4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide-4-nitrobenzoic acid (1/1)
Crystal data (7) 0.0035 (6) 0.0007 (6) N3A 0.0241 (7) 0.0204 (7) 0.0276 (8) 0.0070 (6) 0.0027 (6) 0.0011 (6) N41A 0.0408 (11) 0.0334 (11) 0.0573 (12) 0.0109 (9) 0.0078 (9) 0.0097 (9) C2A 0.0200 (8) 0.0201 (8) 0.0242 (9) 0.0034 (7) 0.0024 (7) 0.0018 (7) C4A 0.0231 (9) 0.0191 (9) 0.0325 (10) 0.0043 (7) 0.0004 (7) 0.0025 (7) C5A 0.0324 (10) 0.0238 (9) 0.0278 (10) 0.0063 (7) −0.0029 (7) 0.0050 (7) C6A 0.0236 (9) 0.0231 (9) 0.0250 (9) 0.0028 (7) 0.0010 (7) 0.0022 (7 
